Neo‐adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma-Reference-Cited by-同舟云学术

Neo‐adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma

Published:2022-03-31 Issue:6 Volume:18 Page:735-742
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clncl Oncology

Author:

Temraz Sally¹^ORCID,Nassar Farah¹,Hammoud Miza Salim¹,Mukherji Deborah¹,O'Reilly Eileen M.²,Dbouk Haifa³,Farhat Fadi⁴,Charafeddine Maya¹,Faraj Walid⁵,Khalifeh Mohammad J.⁵,Abou‐Alfa Ghassan K.²,Shamseddine Ali¹^ORCID

Affiliation:

1. Department of Internal Medicine Hematology/Oncology Division American University of Beirut Medical Center Beirut Lebanon

2. Memorial Sloan‐Kettering Cancer Center New York New York USA

3. Department of Internal Medicine Hematology/Oncology Division Nabih Berri Governmental University Hospital Nabatieh Lebanon

4. Department of Internal Medicine, Hematology/Oncology Division Hammoud Hospital University Medical Center Saida Lebanon

5. Department of Surgery, General surgery Division American University of Beirut Medical Center Beirut Lebanon

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13775

Reference24 articles.

1. SiegelRL MillerKD.Cancer statistics 2019.2019;69(1):7‐34.https://doi.org/10.3322/caac.21551.

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Adjuvant and neoadjuvant treatment in pancreatic cancer

4. Pancreatic Cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antineoplastics;Reactions Weekly;2023-07-01